Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3898-3906.
Prepublished online as a Blood First Edition Paper on August 23, 2005; DOI 10.1182/blood-2005-01-0355.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-01-0355v1
106/12/3898    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zweidler-McKay, P. A
Right arrow Articles by Pear, W. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zweidler-McKay, P. A
Right arrow Articles by Pear, W. S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 26, 2005
Accepted May 22, 2005

Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B cell malignancies

Patrick A Zweidler-McKay, Yiping He, Lanwei Xu, Carlos G Rodriguez, Fredrick G Karnell, Andrea C Carpenter, Jon C Aster, David Allman, and Warren S Pear*

Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA; Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA; Divisions of Hematology & Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA
Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA; Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA
Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA
Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA
Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA

* Corresponding author; email: wpear{at}mail.med.upenn.edu.

Although Notch receptor expression on malignant B-cells is widespread, the effect of Notch signaling in these cells is poorly understood. To investigate Notch signaling in B-cell malignancy, we assayed the effect of Notch activation in multiple murine and human B-cell tumors, representing both immature and mature subtypes. Expression of constitutively-active, truncated forms of the four mammalian Notch receptors (ICN1-4) inhibited growth and induced apoptosis in both murine and human B-cell lines, but not T-cell lines. Similar results were obtained in human precursor B-cell acute lymphoblastic leukemia lines when Notch activation was achieved by co-culture with fibroblasts expressing the Notch ligands Jagged1 or Jagged2. All four truncated Notch receptors, as well as the Jagged ligands, induced Hes1 transcription. Retroviral expression of Hes1 recapitulated the Notch effects suggesting that Hes1 is an important mediator of Notch-induced growth arrest and apoptosis in B-cells. Among the B-cell malignancies that were susceptible to Notch-mediated growth inhibition/apoptosis were mature B-cell and therapy-resistant B-cell malignancies including Hodgkins, myeloma and MLL-translocated cell lines. These results suggest that therapies capable of activating Notch/Hes1 signaling may have therapeutic potential in a wide range of human B-cell malignancies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Zhang and P. J. Gallagher
Mind bomb 1 regulation of cFLIP interactions
Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1275 - C1283.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-O. Yoon, X. Zhang, P. Berner, B. Blom, and Y. S. Choi
Notch Ligands Expressed by Follicular Dendritic Cells Protect Germinal Center B Cells from Apoptosis
J. Immunol., July 1, 2009; 183(1): 352 - 358.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Kohlhof, F. Hampel, R. Hoffmann, H. Burtscher, U. H. Weidle, M. Holzel, D. Eick, U. Zimber-Strobl, and L. J. Strobl
Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells
Blood, May 28, 2009; 113(22): 5506 - 5515.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Rosati, R. Sabatini, G. Rampino, A. Tabilio, M. Di Ianni, K. Fettucciari, A. Bartoli, S. Coaccioli, I. Screpanti, and P. Marconi
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Blood, January 22, 2009; 113(4): 856 - 865.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D.-M. Shin, D. J. Shaffer, H. Wang, D. C. Roopenian, and H. C. Morse III
NOTCH Is Part of the Transcriptional Network Regulating Cell Growth and Survival in Mouse Plasmacytomas
Cancer Res., November 15, 2008; 68(22): 9202 - 9211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Ban, I. M. Bennani-Baiti, M. Kauer, K.-L. Schaefer, C. Poremba, G. Jug, R. Schwentner, O. Smrzka, K. Muehlbacher, D. N.T. Aryee, et al.
EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma
Cancer Res., September 1, 2008; 68(17): 7100 - 7109.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Zhang, Y. Yang, P. A. Zweidler-McKay, and D. P.M. Hughes
Critical Role of Notch Signaling in Osteosarcoma Invasion and Metastasis
Clin. Cancer Res., May 15, 2008; 14(10): 2962 - 2969.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. G. Leong, K. Niessen, I. Kulic, A. Raouf, C. Eaves, I. Pollet, and A. Karsan
Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin
J. Exp. Med., November 26, 2007; 204(12): 2935 - 2948.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Maeda, T. Merghoub, R. M. Hobbs, L. Dong, M. Maeda, J. Zakrzewski, M. R.M. van den Brink, A. Zelent, H. Shigematsu, K. Akashi, et al.
Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF
Science, May 11, 2007; 316(5826): 860 - 866.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Bolos, J. Grego-Bessa, and J. L. de la Pompa
Notch Signaling in Development and Cancer
Endocr. Rev., May 1, 2007; 28(3): 339 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Maier, G. Staffler, A. Hartmann, J. Hock, K. Henning, K. Grabusic, R. Mailhammer, R. Hoffmann, M. Wilmanns, R. Lang, et al.
Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2
J. Virol., October 1, 2006; 80(19): 9761 - 9771.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. G. Leong and A. Karsan
Recent insights into the role of Notch signaling in tumorigenesis
Blood, March 15, 2006; 107(6): 2223 - 2233.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020